LONDON (Reuters) - Shares in Prothena, a biotech company backed by British investor Neil Woodford, plunged 70 percent on Monday after its main drug... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/uXZajP0MrEo/woodford-backed-biotech-prothena-plunges-as-key-drug-fails-idINKBN1HU1Y5
Avista helped some companies restructure their debt in such a way that overseas investors had to take a steep haircut Avista Advisory, the... ...http://www.rediff.com/money/report/rajiv-kochhars-avista-advisory-earned-rs-300-crore-in-4-years/20180418.htm
"While we respect the court#39;s judgement, this order will have wider implications beyond the seed and agri biotech sector," Federation of Seed... ...https://www.moneycontrol.com/news/economy/delhi-hc-order-may-hit-agri-investment-seeds-body_10779181.html
LONDON (Reuters) - GlaxoSmithKline is divesting its rare disease gene therapy drugs to private biotech company Orchard Therapeutics as Chief... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/9xoU2JXQX_M/gsk-slims-portfolio-with-sale-of-rare-disease-gene-therapy-drugs-idINKBN1HJ0V5
(Reuters) - Alexion Pharmaceuticals has agreed to buy Sweden's Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million), boosting its... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/o7D4nqhre6A/biotech-ma-rolls-on-as-alexion-snaps-up-wilson-for-855-million-idINKBN1HI236
Organica Biotech, a leading biotech...
De Novo biotech pvt ltd is prominent...